Abstract:Long noncoding RNAs (lncRNAs) are essential transcripts with critical roles in tumor initiation and malignant progression. In the present study, through analysis of whole-transcriptome profiles, we showed that MIR22 host gene (MIR22HG), the primary microRNA of miR-22, ranked among the most overexpressed lncRNAs in glioblastoma (GBM). Herein, our study aims to elucidate the biological functions of MIR22HG and therapeutic potency of MIR22HG targeted inhibition in GBM. We characterized the expression pattern of MIR22HG/miR-22 by bioinformatics analysis and by in situ hybridization (ISH) in GBMs. We further determined whether genetic targeting of MIR22HG affected oncogenic functions of primary GBM cells in vitro and in vivo. A co-culture model where brain organoids are co-cultured with GBM spheroids were utilized for the invasion assessment. Finally, based on the three-dimensional structure of the pre-miR-22, we performed virtual screening strategy to disclose a novel inhibitor of the MIR22HG/miR-22 axis. We showed that MIR22HG/miR-22 was highly expressed in GBM, especially in isocitrate dehydrogenase 1/2 (IDH1/2) wild-type tumors. Specially, MIR22HG/miR-22 was preferentially expressed in glioblastoma stem cells (GSCs) compared to normal neural stem cell (NSCs). Analysis of intra-tumoral transcriptional heterogeneity showed that MIR22HG was higher in the infiltrating region compared to the tumor center. In functional assays, silencing MIR22HG attenuated aggressive phenotypes in GBM cells, including invasion, self-renewal and in vivo tumor growth via suppressing the production of miR-22-3p and miR-22-5p. Using a luciferase reporter assay, we further confirmed that two inhibitors of the Wnt/β-catenin pathway, SFRP2 and PCDH15, were direct targets of miR-22-3p and miR-22-5p. Finally, we identified a specific inhibitor termed AC1L6JTK, which blocks the ability of Dicer to process pre-miR-22 to mature miR-22, thus exerting therapeutic efficacy on GBMs. Our findings show that the MIR22HG/miR-22 axis is a novel biomarker as well as a therapeutic target in GBM.

Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Downregulation of Long Non-Coding RNA MR4435-2HG Suppresses Breast Cancer Progression Via the Wnt/β-catenin Signaling Pathway.

Lncrna MIR22HG-Derived Mir-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease

Long Noncoding RNA SNHG14 Promotes Breast Cancer Cell Proliferation and Invasion Via Sponging Mir-193A-3p

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review

MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells

MIR17HG: A Cancerogenic Long-Noncoding RNA in Different Cancers

Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer.

Prognostic Values of Long Non-Coding RNA MIR22HG for Patients with Hepatocellular Carcinoma after Hepatectomy.

Based on in vivo and in vitro experiments validation: lncRNA MIR210HG inhibits esophageal squamous cell carcinoma and correlates with autophagy and apoptosis

LncRNA MIR22HG Inhibits Growth, Migration and Invasion Through Regulating the Mir‐10a‐5p/ncor2 Axis in Hepatocellular Carcinoma Cells

MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor

Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression Via Mir-17-5p

Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis

CSIG-28. LONG NONCODING RNA MIR22 HOST GENE-DERIVED miR-22-3p AND miR-22-5p PROMOTE PROLIFERATION, INVASION AND SELF-RENEWAL IN HUMAN GLIOMAS VIA Wnt/-CATENIN SIGNALING

Analysis of Differentially Expressed Long Non‑coding RNAs Revealed a Pro‑tumor Role of MIR205HG in Cervical Cancer

LncRNA MIR17HG Promotes Colorectal Cancer Liver Metastasis by Mediating a Glycolysis-Associated Positive Feedback Circuit

Interfering with Long Non-Coding RNA MIR22HG Processing Inhibits Glioblastoma Progression Through Suppression of Wnt/β-catenin Signalling